nasal irrigation nasal irrigation
Conditions
Interventions
Participants were included in the study and randomized into either the NasiCare or placebo group.
NasiCare is novel automated nasal irrigation device with normal saline.
Placebo group is standard syr
Experimental Device,Active Comparator Device
NasiCare,Syringe irrigation
Sponsors
GENERAL HOSPITAL PRODUCTS PUBLIC COMPANY LIMITED
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: healthy adult participants
Exclusion criteria
Exclusion criteria: 1. underlying disease involving upper respiratory tract such as allergic rhinitis, sinusitis or nasal polyp. 2. Hx of previous upper respiratory tract infection within 2 weeks 3. Hx of intranasal corticosteroid or intranasal/oral antihistamine or nasal decongestant medication within 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| nasal saccharin transit time at the end of nasal irrigation time to feel bitter taste after saccharin placement (second) | — |
Secondary
| Measure | Time frame |
|---|---|
| satisfication score at the end of test participant reported score (0-10),side effect of irrigation device at the end of test participant reported (yes or no) | — |
Countries
Thailand
Contacts
Public ContactPICHANON WACHARAPRAPAPONG
THAMMASAT UNIVERSITY HOSPITAL
Outcome results
None listed